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ABSTRACT. The influence of intravenously administered L-
carnitine on lipid- and nitrogen-metabolism was studied during
total parenteral nutrition of piglets (mean weight 4077 g; n =
9). The infusion protocol was divided into three isocaloric and
isonitrogenous 48-hr periods. Amino acids (3 g/kg day) were
administered throughout all three periods: 140 cal/kg/day were
given as nonprotein calories, consisting only of glucose during
period 1; during periods 2 and 3, an amount of glucose calori-
cally equivalent to 4 g fat/kg/day was substituted with a lipid
emulsion, and L-carnitine (1.5 mg/kg/day) was added in period
3. Key parameters of fat- and nitrogen-metabolism were deter-
mined during the entire regime. Indirect calorimetry was per-
formed and the respiratory quotient calculated during all three
periods. The results demonstrate a more effective lipolysis and
oxydation of fatty acids during L-carnitine supplementation.
These changes produce an increased energy gain from exoge-
nously administered fat and a distinct improvement in nitrogen
balance. (Journal of Parenteral and Enteral Nutrition 8:9-13,
1983)
Infants switch their oxydative metabolism during the
newborn period from the predominant use of carbohy-
drates to fat/ In the oxydative degradation of fatty acids,
carnitine is essential for the transfer of activated long-
chain fatty acids across the inner mitochondrial mem-
brane.’ The capacity for carnitine synthesis is limited in
premature infants,’ and decreased carnitine concentra-
tions in serum and tissue can be demonstrated in new-
borns maintained on total parenteral nutrition (TPN).4-6
Carnitine supplementation of infants should therefore
be taken into consideration during TPN. However, from
a general point of view, the metabolic effects of intrave-
nously administered carnitine have to be clarified. The
aim of the present study was to elucidate the effects of
L-carnitine supplementation during TPN, using a piglet
model.
MATERIALS AND METHODS
Experimental Animals
Nine male piglets (mini pigs, Gottingen, Federal Re-
public of Germany), with an average body weight of 4077
g, were used in this study. This animal species appeared
to be appropriate because of their metabolic similarities
to infants .7, ’ Their use was approved by the Government.
Operations
The external jugular vein was exposed by a lateral
neck incision. A catheter was inserted into the right
atrium of the heart and threaded subcutaneously to exit
from the back of the neck. For continuous urine collec-
tion, a catheter was inserted into the bladder and secured
by a purse-string suture. The urethra was ligated, and
the animals were placed in hammocks after the opera-
tions (Fig. 1). They were unrestrained and could move
about freely, but remained quiet without medical seda-
tion, and received all nutrients via the central venous
route. Urine was collected continuously and stored at
-20°C until analysis.
ExperimentaL Design
The study commenced postoperatively, after a 48-hr
adaptation period, along the lines of the experimental
design demonstrated in Figure 2. The TPN protocol was
divided into three isocaloric and isonitrogenous 48-hr
periods: 3 g/kg day of amino acids (Aminofusin pad 5%)
were administered throughout all three periods; 140 cal/
kg/day were given as nonprotein calories, consisting only
of glucose during period 1; during periods 2 and 3, an
amount of glucose calorically equivalent to 4 g fat/kg/
day was substituted with a 20% lipid emulsion (Lipofun-
din S 20%). L-Carnitine (1.5 mg/kg/day) was added in
period 3.
Indirect Calorimetry
The animals were placed under a hood, as shown in
Figure 1, and an airflow of about 1-2 liters/min was
produced with a membrane pump. When compared with
room air, differences in O~ and C02 concentrations of
about 1-1.5 volume% were observed. Gas concentrations
were measured continuously three times per day during
2-hr periods and the CO:j02 ratios respiratory quotient
(RQ) were calculated. The O2 and C02 concentrations
were determined using the paramagnetic properties of 02
and infrared absorption of C02.
Chemical Analysis
Free fatty acids were measured according to the meth-
odology of Trout et al,~ while ¡3-0H--butyric acid was
determined enzymatically according to the technique of
Bergmeyer and Bernt.&dquo;’ Both analyses were performed
within 5 min of blood sampling.
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FIG. 1. Experimental design for TPN and indirect calorimetry. P,
membrane pump (airflow: 1-2 liter/min). A, amino acid solution (5%).
F, lipid emulsion (20%). G, glucose solution. U, urine collection.
Triglycerides were assessed enzymatically (Testomar-
Triglyzeride, Behringwerke, Germany), and serum glyc-
erol was quantitated using the test for triglycerides but
without performing the initial alkaline hydrolysis. a-
NH3-nitrogen was measured in urine according to the
procedure described by Pope and Stevens.ll Total urinary
nitrogen was determined according to Kieldahl’s
method.&dquo; Serum glucose, urea-N, lactate, and insulin
were assessed with techniques routinely used in clinical
laboratories. Carnitine was quantitated according to the I
methodology of McGarry and Foster 13 before (free car-
nitine) and after alkaline hydrolysis (total carnitine).
Acyl carnitine was calculated from differences between
total and free carnitine.
Statistical Analysis
The data were analyzed statistically according to Wil-
coxon’s nonparametric test.
RESULTS
The metabolic changes during the individual infusion
periods are listed in Table I. In period 1, the serum
FIG. 2. Experimental design of TPN protocol.
TABLE I
Changes in metabolic parameters of serum and urine (mean ± 1 SD)
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triglyceride concentration was slightly below normal val-
ues for pigs, but showed an increase during infusion of
the lipid emulsion in period 2. Free fatty acids also
revealed elevated values, and the mean concentration of
serum glycerol, the other split product of triglycerides,
was augmented when periods 1 and 2 were compared.
Lipid administration during period 2 elicited no rise in
serum ¡3-0H-butyric acid concentrations, but ¡3-0H-bu-
tyric acid excretion in urine was accelerated.
The RQ reflected the oxydation of carbohydrates dur-
ing period 1 and responded to the administration of lipids
with a significant decrease in period 2. Although carni-
tine was not added in period 2, the serum concentration
of total carnitine showed a significant elevation which
was mainly due to acyl carnitine. However, total urinary
carnitine excretion fell after lipid administration and
was enhanced after L-carnitine supplementation in pe-
riod 3.
Period 3 witnessed a decrease of serum triglycerides
and free fatty acids with an increase in the mean serum
glycerol concentration. Ketone bodies, represented by 13-
OH-butyric acid, were elevated in serum and urine during
period 3. After carnitine was given, its total serum con-
centration rose significantly but only to a minor extent
when compared with the elevation seen in period 2.
Again, this increment was mainly due to acyl carnitine.
A further decline of the RQ, in period 3, demonstrated
an augmentation of fatty acid oxydation. There was a
significant correlation between serum acyl carnitine and
serum ¡3-0H-butyric acid as well as an inverse correlation
between ¡3-0H-butyric acid and free fatty acids (r =
-0.71; p < 0.001).
A positive nitrogen balance was evident during all
three periods of TPN. There was no significant difference
between nitrogen retention in period 1 (+0.35 ± 0.11 g
N/day) and period 2 (+0.26 ± 0.12 g N/day). However,
significantly more nitrogen was retained after carnitine
supplementation in period 3 (+0.85 ± 0.36 g N/day; p <
0.01) (Fig. 3). The nitrogen balance data were confirmed
by changes in the amount of urea-N and a-NH3-N ex-
creted during period 3 (p < 0.01) (Fig. 4).
The serum concentrations of glucose, lactate, insulin,
and urea-N showed slight but nonsignificant alterations
during the three infusion periods (Table II). However,
FIG. 3. Nitrogen balance data during the three infusion periods.
FIG. 4. Urinary urea-N and a-NH3-N-excretion (mean ± 1 SD).
TABLE II
Changes in metabolic serum parameters; the differences are statistically
nonsignificant (mean ± 1 SD)
the mean of the urea-N concentration was decreased
considerably during carnitine supplementation.
DISCUSSION
The observed metabolic differences between periods 1
and 2 reflect the transition to the infusion of lipids. The
RQ proves a change from an almost exclusively carbo-
hydrate oxydation to a mixed oxydative degradation of
glucose and fat. /3-oxydation was not effectively stimu-
lated during period 2, as can be concluded from the
increased concentrations of free fatty acids and the bas-
ically unchanged ¡3-0H-butyric acid concentrations.3 3
This conclusion is supported by the inverse correlation
between free fatty acids and ¡3-0H-butyric acid.
Without exogenous carnitine supplementation in pe-
riod 2, there was an elevation of all serum carnitine
fractions and a decline of total carnitine excretion in
urine. A similar decrease could be observed by other
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investigators during the fasting state,14 during alimen-
tation with a carnitine-deficient diet’5 as well as during
TPN of premature infants without carnitine supplemen-
tation.3-’ This phenomenon is generally interpreted as a
regulatory action of the kidney to preserve carnitine
stores.3. 16. 1í An increase of serum carnitine concentra-
tions-which is mainly caused by acyl carnitine-was
observed in fasting rats by Brass and Hoppel.16 Frohlich
et all’ reported comparable results for healthy fasting
adults, while McGarry et ap8 demonstrated a rise in
tissue carnitine concentrations during increased keto-
genesis. In young infants, after a lipid infusion (1 g/kg
over 4 hr), Schmidt-Sommerfeld and Penn6 noted unal-
tered serum concentrations of total carnitine with a
change in the carnitine fractions in favor of acyl carni-
tine. Because of the short-term nature of the infusions,
these results are not comparable to our long-term TPN
data. However, the lack of an increase of total carnitine
concentrations during short-term lipid infusion on the
one hand and a significant elevation after long-term lipid
application on the other may indicate the induction of
de nouo enzymatic synthesis of carnitine from lysine and
methionine.
Augmented serum carnitine concentrations are be-
lieved to reflect improved carnitine availability,&dquo; and
serum acyl carnitine is of major importance in fatty acid
oxydation.3 Acyl carnitine is increased in the case of high
fatty acid turnover and ketogenesis 19 and explains the
correlation between acyl carnitine and ¡3-0H-butyric
acid,6,16 which we could confirm.
Abnormally low serum carnitine concentrations have
been observed in premature infants on carnitine-free
TPN.3 This departure from our own results could be
explained on the basis of a different situation of body
carnitine stores on the one hand and immature synthesis
in the premature infant on the other.2° During the period
of exogenous carnitine supplementation, all measured
metabolites of lipid metabolism indicated an enhance-
ment of fatty acid oxydation, which could be proved by
the further significant decrease of the RQ in period 3.
This change in the RQ corresponds to that observed by
Kerr et a 121 in a patient with systemic carnitine defi-
ciency which decreased from 0.92 to 0.78 during carnitine
supplementation. Similarly, an enhanced oxygen con-
sumption could be demonstrated in fat tissue cells after
the addition of carnitine.’ Novak et a122 documented a
carnitine-induced increase of glycerol in the subcuta-
neous tissue of newborns. The fall of triglyceride concen-
trations, which occurred simultaneously to an increase
of serum glycerol, indicates that lipolysis was enhanced.
We, therefore, confirm the idea that, besides the stimu-
lation of fatty acid oxydation, carnitine is involved in
the regulation of lipolysis.’
The essential meaning of the changes in lipid metab-
olism, demonstrated after carnitine supplementation, is
an improved energy gain from exogenously administered
lipids, which is reflected in an improved nitrogen balance.
The decreased excretion of urea-N and alpha-NH3-N
after carnitine supplementation is a necessary equivalent
of the changes in nitrogen balance. The slight fall in
serum urea-N concentrations may also be indicative of
better nitrogen utilization. Our animal study could ob-jectively confirm the improvement of growth that hith-
erto was only empirically described.23> 24
CONCLUSIONS
The present results suggest that L-carnitine supple-
mentation during TPN with lipid emulsions induces: (1)
an increased lipolysis; (2) an enhanced oxydation of fatty
acids; and (3) an improved nitrogen retention via a better
energy supply from the infused lipids.
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